Study of the Chemical Profile and Anti-Fungal Activity against Candida auris of Cinnamomum cassia Essential Oil and of Its Nano-Formulations Based on Polycaprolactone
- PMID: 36679069
- PMCID: PMC9860731
- DOI: 10.3390/plants12020358
Study of the Chemical Profile and Anti-Fungal Activity against Candida auris of Cinnamomum cassia Essential Oil and of Its Nano-Formulations Based on Polycaprolactone
Abstract
Background: Candida auris represents an emerging pathogen that results in nosocomial infections and is considered a serious global health problem. The aim of this work was to evaluate the in vitro antifungal efficacy of Cinnamomum cassia essential oil (CC-EO) pure or formulated in polycaprolactone (PCL) nanoparticles against ten clinical strains of C. auris.
Methods: nanoparticles of PCL were produced using CC-EO (nano-CC-EO) and cinnamaldehyde (CIN) through the nanoprecipitation method. The chemical profile of both CC-EO and nano-CC-EO was evaluated using SPME sampling followed by GC-MS analysis. Micro-broth dilution tests were performed to evaluate both fungistatic and fungicidal effectiveness of CC-EO and CIN, pure and nano-formulated. Furthermore, checkerboard tests to evaluate the synergistic action of CC-EO or nano-CC-EO with micafungin or fluconazole were conducted. Finally, the biofilm disrupting activity of both formulations was evaluated.
Results: GC-MS analysis shows a different composition between CC-EO and nano-CC-EO. Moreover, the microbiological analyses do not show any variation in antifungal effectiveness either towards the planktonic form (MICCC-EO = 0.01 ± 0.01 and MICnano-CC-EO = 0.02 ± 0.01) or the biofilm form. No synergistic activity with the antifungal drugs tested was found.
Conclusions: both CC-EO and nano-CC-EO show the same antimicrobial effectiveness and are potential assets in the fight against C. auris.
Keywords: antifungal properties; cinnamaldehyde; cinnamon.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Synergistic Effect of Essential Oils and Antifungal Agents in Fighting Resistant Clinical Isolates of Candida auris.Pharmaceutics. 2024 Jul 19;16(7):957. doi: 10.3390/pharmaceutics16070957. Pharmaceutics. 2024. PMID: 39065654 Free PMC article.
-
A New Potential Resource in the Fight against Candida auris: the Cinnamomum zeylanicum Essential Oil in Synergy with Antifungal Drug.Microbiol Spectr. 2023 Mar 28;11(2):e0438522. doi: 10.1128/spectrum.04385-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36975835 Free PMC article.
-
Chemical composition and tyrosinase inhibitory activity of Cinnamomum cassia essential oil.Bot Stud. 2013 Dec;54(1):10. doi: 10.1186/1999-3110-54-10. Epub 2013 Aug 21. Bot Stud. 2013. PMID: 28510850 Free PMC article.
-
Emerging and future strategies in the management of recalcitrant Candida auris.Med Mycol. 2022 Mar 17;60(4):myac008. doi: 10.1093/mmy/myac008. Med Mycol. 2022. PMID: 35142862 Free PMC article. Review.
-
Candida auris, a singular emergent pathogenic yeast: its resistance and new therapeutic alternatives.Eur J Clin Microbiol Infect Dis. 2022 Dec;41(12):1371-1385. doi: 10.1007/s10096-022-04497-2. Epub 2022 Oct 6. Eur J Clin Microbiol Infect Dis. 2022. PMID: 36198878 Review.
Cited by
-
Cinnamaldehyde Loaded Poly(lactide-co-glycolide) (PLGA) Microparticles for Antifungal Delivery Application against Resistant Candida albicans and Candida glabrata.Plants (Basel). 2023 Jun 24;12(13):2437. doi: 10.3390/plants12132437. Plants (Basel). 2023. PMID: 37446996 Free PMC article.
-
Essential Oils against Candida auris-A Promising Approach for Antifungal Activity.Antibiotics (Basel). 2024 Jun 19;13(6):568. doi: 10.3390/antibiotics13060568. Antibiotics (Basel). 2024. PMID: 38927234 Free PMC article. Review.
-
An Overview on Candida auris in Healthcare Settings.J Fungi (Basel). 2023 Sep 8;9(9):913. doi: 10.3390/jof9090913. J Fungi (Basel). 2023. PMID: 37755021 Free PMC article. Review.
-
Is Silver Addition to Scaffolds Based on Polycaprolactone Blended with Calcium Phosphates Able to Inhibit Candida albicans and Candida auris Adhesion and Biofilm Formation?Int J Mol Sci. 2024 Feb 28;25(5):2784. doi: 10.3390/ijms25052784. Int J Mol Sci. 2024. PMID: 38474027 Free PMC article.
-
Synergistic Effect of Essential Oils and Antifungal Agents in Fighting Resistant Clinical Isolates of Candida auris.Pharmaceutics. 2024 Jul 19;16(7):957. doi: 10.3390/pharmaceutics16070957. Pharmaceutics. 2024. PMID: 39065654 Free PMC article.
References
-
- Ministero della Salute . Candida auris in Ambito Sanitario–Rapid Risk Assessment. Ministero della Salute; Rome, Italy: 2020.
-
- Ministero della Salute . Aggiornamento Delle Raccomandazioni per Il Controllo Dell’infezione Da Candida auris in Italia. Ministero della Salute; Rome, Italy: 2020.
-
- Ministero della Salute . Aggiornamento Delle Raccomandazioni per Il Controllo Dell’infezione Da Candida auris in Italia. Ministero della Salute; Rome, Italy: 2021.
LinkOut - more resources
Full Text Sources
Miscellaneous